About Serán BioScience
Serán BioScience is a company based in Bend (United States) founded in 2016 by Dan Smithey was acquired by Vivo Capital in January 2021. Serán BioScience offers products and services including Preformulation Services, Formulation Development, Dosage Form Development, Spray Drying and Particle Engineering, and cGMP Manufacturing. Serán BioScience operates in a competitive market with competitors including Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.
- Headquarter Bend, United States
- Founders Dan Smithey
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Serán Bioscience, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Bain Capital Life Sciences
& 1 more
-
Employee Count
Not available
-
Acquired by
Vivo Capital
(Jan 08, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Serán BioScience
Serán BioScience offers a comprehensive portfolio of products and services, including Preformulation Services, Formulation Development, Dosage Form Development, Spray Drying and Particle Engineering, and cGMP Manufacturing.
Early analysis and optimization of drug properties for formulation.
Design and testing of stable drug formulations for efficacy.
Creation of various dosage forms for clinical applications.
Engineering particles to improve drug delivery and stability.
Production of drugs under cGMP standards for clinical use.
People of Serán BioScience
Unlock access to complete
Funding Insights of Serán BioScience
Investors in Serán BioScience
Serán BioScience has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Bain Capital Life Sciences and Vivo Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Locked | Locked | Locked | |
|
Venture capital and private equity firm
|
Locked | Locked | Locked |
Investor details for Serán BioScience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Serán BioScience
Investment portfolio details for Serán BioScience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Serán BioScience
Detailed financials for Serán BioScience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Serán Bioscience Comparisons
Peer comparison for Serán BioScience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Serán BioScience
Serán BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
AI powered scientific data management and workflow automation solutions
|
|
| Locked | Locked | Locked |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
Detailed competitors of Serán BioScience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Serán Bioscience
Complete news archive for Serán BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Serán BioScience
Serán BioScience was founded in 2016 and raised its 1st funding round 8 years after it was founded.
Serán BioScience is headquartered in Bend, United States. It is registered at Bend, Oregon, United States.
Dan Smithey is the current CEO of Serán BioScience. They have also founded this company.
Serán BioScience, founded in 2016 in Bend, United States, focuses on providing healthcare solutions, biopharma outsourcing, diversified, and small molecules peptides. Provider of drug development, manufacturing and regulatory services. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Serán BioScience offers Preformulation Services, Formulation Development, Dosage Form Development, Spray Drying and Particle Engineering, and cGMP Manufacturing.
Serán BioScience has 2 investors. Key investors include Bain Capital Life Sciences, and Vivo Capital.